Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
Clinical trial NCT04279314 · COMPLETED
Trial details
- NCT number
- NCT04279314
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2022-08-19
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.